EcoDrugPlus

Ribosomal Protein L39

Ensembl ID : ENSAPOG00000012798
Gene Symbol: RPL39
3 Cross references
371 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSAPOG00000008471
Gene Symbol: RPL4
3 Cross references
340 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSAPOG00000011544
Gene Symbol: RPL5
3 Cross references
401 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSAPOG00000011385
Gene Symbol: RPL5
3 Cross references
401 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSAPOG00000015269
Gene Symbol: RPL5
3 Cross references
457 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSAPOG00000014868
Gene Symbol: RPL5
4 Cross references
452 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSAPOG00000004958
Gene Symbol: RPL6
3 Cross references
487 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSAPOG00000002965
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSAPOG00000020989
Gene Symbol: RPL7A
4 Cross references
372 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSAPOG00000007833
Gene Symbol: RPL9
3 Cross references
505 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSAPOG00000010000
Gene Symbol: RPS10
3 Cross references
384 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSAPOG00000001274
Gene Symbol: RPS11
3 Cross references
287 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).